MediWound (MDWD) Competitors $16.00 -0.37 (-2.26%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends MDWD vs. FOMX, NAII, SNDL, MTEX, CDXC, ABUS, RLAY, EXAI, CRMD, and NUVBShould you be buying MediWound stock or one of its competitors? The main competitors of MediWound include Menlo Therapeutics (FOMX), Natural Alternatives International (NAII), SNDL (SNDL), Mannatech (MTEX), ChromaDex (CDXC), Arbutus Biopharma (ABUS), Relay Therapeutics (RLAY), Exscientia (EXAI), CorMedix (CRMD), and Nuvation Bio (NUVB). These companies are all part of the "medical" sector. MediWound vs. Menlo Therapeutics Natural Alternatives International SNDL Mannatech ChromaDex Arbutus Biopharma Relay Therapeutics Exscientia CorMedix Nuvation Bio MediWound (NASDAQ:MDWD) and Menlo Therapeutics (NASDAQ:FOMX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, community ranking, risk and valuation. Do institutionals and insiders hold more shares of MDWD or FOMX? 46.8% of MediWound shares are held by institutional investors. Comparatively, 46.5% of Menlo Therapeutics shares are held by institutional investors. 9.2% of MediWound shares are held by insiders. Comparatively, 3.0% of Menlo Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has preferable valuation and earnings, MDWD or FOMX? MediWound has higher revenue and earnings than Menlo Therapeutics. MediWound is trading at a lower price-to-earnings ratio than Menlo Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMediWound$18.69M9.24-$6.72M-$2.16-7.41Menlo Therapeutics$3.60M51.15-$74.16M-$1.70-1.76 Which has more volatility and risk, MDWD or FOMX? MediWound has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Menlo Therapeutics has a beta of 1.66, indicating that its share price is 66% more volatile than the S&P 500. Is MDWD or FOMX more profitable? Menlo Therapeutics has a net margin of 0.00% compared to MediWound's net margin of -99.17%. MediWound's return on equity of -52.49% beat Menlo Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets MediWound-99.17% -52.49% -21.92% Menlo Therapeutics N/A -100.58%-81.39% Do analysts prefer MDWD or FOMX? MediWound currently has a consensus target price of $29.00, suggesting a potential upside of 81.25%. Given MediWound's stronger consensus rating and higher probable upside, research analysts plainly believe MediWound is more favorable than Menlo Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MediWound 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Menlo Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in MDWD or FOMX? MediWound received 132 more outperform votes than Menlo Therapeutics when rated by MarketBeat users. However, 65.58% of users gave Menlo Therapeutics an outperform vote while only 62.09% of users gave MediWound an outperform vote. CompanyUnderperformOutperformMediWoundOutperform Votes39362.09% Underperform Votes24037.91% Menlo TherapeuticsOutperform Votes26165.58% Underperform Votes13734.42% Does the media prefer MDWD or FOMX? In the previous week, MediWound had 2 more articles in the media than Menlo Therapeutics. MarketBeat recorded 3 mentions for MediWound and 1 mentions for Menlo Therapeutics. MediWound's average media sentiment score of 1.17 beat Menlo Therapeutics' score of 0.00 indicating that MediWound is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MediWound 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Menlo Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryMediWound beats Menlo Therapeutics on 12 of the 18 factors compared between the two stocks. Ad DTILet’s be bluntLet me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now Get MediWound News Delivered to You Automatically Sign up to receive the latest news and ratings for MDWD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDWD vs. The Competition Export to ExcelMetricMediWoundMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$172.58M$1.33B$5.12B$8.72BDividend YieldN/AN/A5.18%4.07%P/E Ratio-7.4127.2572.8114.16Price / Sales9.247.631,250.2081.71Price / CashN/A12.6840.7036.03Price / Book4.661.956.455.94Net Income-$6.72M-$52.95M$119.73M$225.73M7 Day Performance-7.43%-2.37%-5.13%-1.34%1 Month Performance-11.65%-2.50%-2.71%1.15%1 Year Performance92.08%7.07%31.08%24.02% MediWound Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDWDMediWound2.0177 of 5 stars$16.00-2.3%$29.00+81.3%+93.2%$172.58M$18.69M-7.4180Positive NewsFOMXMenlo TherapeuticsN/A$2.99flatN/AN/A$184.12M$3.60M-2.3080NAIINatural Alternatives International0.7662 of 5 stars$4.53flatN/A-26.2%$28.09M$113.80M-3.15290Short Interest ↑SNDLSNDL3.8991 of 5 stars$1.95flatN/A+36.4%$323.74M$911.22M-6.292,516MTEXMannatech1.1922 of 5 stars$8.44+12.4%N/A-7.7%$15.87M$131.96M-10.42250Earnings ReportGap UpCDXCChromaDex4.2923 of 5 stars$6.82-5.3%N/A+367.1%$520.91M$83.57M682.68106Short Interest ↓Gap DownABUSArbutus Biopharma2.8115 of 5 stars$3.64+0.3%N/A+96.8%$689.74M$18.14M-8.4673Short Interest ↓News CoverageRLAYRelay Therapeutics3.4835 of 5 stars$5.11-8.8%N/A-36.7%$683.51M$25.55M-1.96304EXAIExscientia2.7457 of 5 stars$4.69-11.7%N/A-21.4%$674.47M$17.07M-3.11280News CoverageHigh Trading VolumeCRMDCorMedix2.7222 of 5 stars$10.33-6.1%N/A+171.8%$667.45M$12.26M-12.7530Short Interest ↓NUVBNuvation Bio2.3415 of 5 stars$2.63-8.4%N/A+101.5%$655.51M$2.16M-1.2160High Trading Volume Related Companies and Tools Related Companies Menlo Therapeutics Alternatives Natural Alternatives International Alternatives SNDL Alternatives Mannatech Alternatives ChromaDex Alternatives Arbutus Biopharma Alternatives Relay Therapeutics Alternatives Exscientia Alternatives CorMedix Alternatives Nuvation Bio Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MDWD) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediWound Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediWound With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDWD Stock Alerts